References
- References
- Puoti C, Magrini A, Stati T, Rigato P, Montagnese F, Rossi P, et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology 1997; 26: 1393–8.
- Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H, et al. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology 1994; 19: 871–5.
- Morsica G, Chemello L, Cavaletto D, Noventa F, Pontisso P, Ruol A. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992; 340: 697–8.
- Marcellin P, Levy S, Erlinger S. Therapy of hepatitis C: patients with normal aminotransferase levels. Hepatology 1997; 26 Suppl 1: 133S–6S.
- Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C. Effects of dose and duration. Hepatology 1996; 24: 778–89.
- Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelneau C, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-a therapy. Ann Intern Med 1997; 127: 875–81.
- Serfaty L, Chazouilleres O, Pawlotsky JM, Andreani T, Pellet C, Poupon R. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology 1996; 110: 291–5.
- Sangiovanni A, Morales R, Spinzi G, Rumi M, Casiraghi A, Ceriani R, et al. Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study. Hepatology 1998; 27: 853–6.
- Silverman AL, Piquette DL, Filipiak CL, Neill JS, Bayati N, Gordon SC. Alpha-interferon treatment of HCV-RNA-positive patients with normal or near normal ALT levels. Am J Gastroenterol 1997; 92: 1793–5.
- Ideo G, Bellobuono A, Tempini S, Mondazzi L, Bellati G, Zanetti AR. Poor efficacy of alpha interferon treatment in patients affected by chronic hepatitis C with normal or near normal ALT levels [abstract]. Gastroenterology 1996; 110: A1215.
- Areias J, Pedroto I, Freitas R, Cerqueira R, Teixeira R, Pinho L, et al. Hepatitis C virus carriers with normal ALT activity: viremia, genotype and effect of interferon therapy [abstract]. Gastroenterology 1996; 110: A1143.
- Nordøy I, Krarup HB, Bell H, Christensen PB, Elgjo K, Von der Lippe B, et al. Interferon-a2b therapy in low-activity hepatitis C: a pilot study. Scand J Gastroenterol 1997; 32: 1256–60.
- Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995; 22: 1050–6.
- Doglio A, Laffont C, Thyss S, Lefebvre JC. Rapid genotyping of hepatitis C virus by direct cycle sequencing of PCR-amplified cDNAs and capillary electrophoresis analysis. Res Virol 1998; 149: 219–27.
- The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15–20.
- Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825–32.
- Zylberberg H, Nalpas B, Brechot C, Berthelot P. Significance of repeatedly normal aminotransferase activities in hepatitis C virus-infected patients. Hepatology 1998; 27: 1169.
- Mathurin P, Moussalli J, Cadranel JF, Thibault V, Charlotte F, Dumouchel P, et al. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology 1998; 27: 868–72.
- Wejstal R, Widell A, Norkrans G. HCV-RNA levels increase during pregnancy in women with chronic hepatitis C. Scand J Infect Dis 1998; 30: 111–3.
- Rossini A, Ravaggi A, Biasi L, Agostinelli E, Bercich L, Gazzola GB, et al. Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis. Hepatology 1997; 26: 1012–7.
- Persico M, Persico E, Suozzo R, Sasso FC, Torella R. Natural history of hepatitis C virus carriers with persistently normal transaminase levels [abstract]. Hepatology 1998; 28: 232A.